Results 51 to 60 of about 834,173 (313)

How government-public collaboration affects individual mitigation responses to flooding: A case study in Yellow River Delta area, China

open access: yesForest and Society, 2023
In the top-down Chinese political system, flood management has traditionally been led by the government, with the general public playing a supporting role.
Lei Xie, Yijie Wang, Shuang Li
doaj   +1 more source

Global governance by goal-setting: the novel approach of the UN Sustainable Development Goals: Open issue, part II

open access: yes, 2017
The 17 Sustainable Development Goals (SDGs) of the United Nations present a novel approach to global governance where goal-setting features as a key strategy.
Global Sustainability Governance   +4 more
core   +1 more source

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke   +4 more
wiley   +1 more source

Corporate governance principles and recommendations (3rd ed.) [PDF]

open access: yes, 2014
Following a comprehensive review in 2012-13, the 21 members of the ASX Corporate Governance Council (“Council”) agreed that it was an appropriate time to issue a third edition of the Principles and Recommendations.
ASX Corporate Governance Council
core  

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook   +6 more
wiley   +1 more source

Disease control programme support costs: an update of WHO-CHOICE methodology, price databases and quantity assumptions

open access: yesCost Effectiveness and Resource Allocation, 2017
Background Estimating health care costs, either in the context of understanding resource utilization in the implementation of a health plan, or in the context of economic evaluation, has become a common activity of health planners, health technology ...
Melanie Y. Bertram   +6 more
doaj   +1 more source

Regulatory governance pathways to improve the efficacy of Australian food policies

open access: yesAustralian and New Zealand Journal of Public Health, 2022
Background: Effective regulatory governance, which entails the actors, processes and contexts within which policies are developed, designed and implemented, is crucial for food policies to improve food environments, consumer behaviour and diet‐related ...
Yandisa Ngqangashe, Sharon Friel
doaj   +1 more source

Contesting Legitimacy in Global Environmental Governance: An Exploration of Transboundary Climate Risk Management in the Brazilian-German Coffee Supply Chain [PDF]

open access: yes, 2022
Stronger interconnections between people, ecosystems and economies in a globalized world are changing the scope and nature of global environmental governance.
Dzebo, Adis   +2 more
core   +1 more source

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance ...
Laura Almási   +14 more
wiley   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy